Eli Lilly and Company is expanding into psychedelic and neuroscience pipelines, adding late-stage psychedelic assets through acquisition.
Steady: 1 in the last 7 days
Updated saturday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company is expanding into psychedelic and neuroscience pipelines, adding late-stage psychedelic assets through acquisition.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Eli Lilly and Company now owns the drugmaker AtaiBeckley.Sub-event
AtaiBeckley received FDA Breakthrough Therapy Designation for its psychedelic drug BPL-003.1 source
Eli Lilly is expanding its pipeline into psychedelic and neuroscience assets through acquisitions.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company